NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Davies SM, Geppert J, McClellan M, et al. Refinement of the HCUP Quality Indicators. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001 May. (Technical Reviews, No. 4.)
These data collection instruments were used in the preliminary and full abstraction phases of the Phase1 literature review: "Identifying indicators". Three forms are provided in the following order: 1.) Full article abstraction, 2.) Risk adjustment, and 3.) Initial screening. They provide a structured mechanism for data collection. However, currently most literature available does not provide the level of detail required by these forms. These forms may be useful for future projects once the health care quality literature expands to include more validation studies and detailed reports of potential indicators.
Abstractor's Initials:
Date Abstracted:
Indicator Data Collection Instrument
UCSF-Stanford EPC/AHCPR HCUP
QI
Measure Header | |||||||||||||||||
Measure Set Name (e.g., HEDIS, DEMPAQ): | |||||||||||||||||
Developer Subset Name | |||||||||||||||||
Performance Measure Name: | |||||||||||||||||
Measure Code: | System assigned | ||||||||||||||||
Type of Measure: (structure/process/proxy-outcome/outcome) | |||||||||||||||||
Year Published: | |||||||||||||||||
Year Most Recently Updated: ("Update"= change in construction of measure) | |||||||||||||||||
Developer
| |||||||||||||||||
Contact Person (if different from Developer)
| |||||||||||||||||
Technical Support Available: | YES | NO | Unclear (For published work, contact author may have information on support by commercial organization). | ||||||||||||||
Measure Detail | |||||||||||||||||
Type of Measure: The activity or area of major concentration |
Mortality Readmission Complication length of stay avoidable hospitalization potentially overused procedure potentially underused procedure other | ||||||||||||||||
Enhancement Area: These are the areas AHCPR has asked us to focus on. You may choose more than one- as many as are applicable. | Chronic medical condition | Avoid. Hospit. | Pediatrics | New Technol. | None | ||||||||||||
Clinical Domain: One of these options should be chosen based on article. Check all that apply. | Medical | surgical | pediatric | obstetric | psychiatric | ||||||||||||
Level of Intervention |
primary
prevention (health promotion, disease
prevention) secondary prevention (screening, early detection) tertiary prevention (optimal treatment of established disease to prevent complications/death) | ||||||||||||||||
Measure Rationale | . | ||||||||||||||||
Scoring method (e.g., percentage, proportion, rank, mean, median, etc.) |
rate
(events/person-time at risk) ratio (events/events, where the numerator is not a subset of the denominator) mean median proportion/percentage (death/complication "rate") index or score rank or percentile range standard deviation or variance odds ratio or relative risk hazard rate z score (standardized difference) other | ||||||||||||||||
Quality Standard: (if suggested a priori by developer or sponsor) |
accepted
benchmark external comparison institutional comparison | ||||||||||||||||
Numerator Statement: A statement that depicts the portion of the denominator population that satisfies the condition of the performance measure to be an indicator event. (ICD-9 diagnosis or procedure codes, DRG codes, MDC codes, or Revenue Center Codes) | |||||||||||||||||
Denominator Statement: A statement that depicts the population evaluated.. (ICD-9 diagnosis or procedure codes, DRG codes, MDC codes, CPT or Revenue Center Codes) | |||||||||||||||||
Population Inclusions (numerator): Additional information describing the population(s) not contained in the numerator statement. | |||||||||||||||||
Population Inclusions (denominator): Additional information describing the population(s) not contained in the denominator statement | |||||||||||||||||
Population Exclusions (numerator): Additional information describing the population(s) that should not be included in the numerator | |||||||||||||||||
Population Exclusions (denominator): Additional information describing the population(s) that should not be included in the denominator | |||||||||||||||||
Longitudinal Data Required: The measure requires the ability to match patient discharges over time |
yes no | ||||||||||||||||
Additional Data Sources Required: (e.g., area population counts, etc.) Check all that apply, indicate specific data source (e.g. population/ census birth certificate) |
population/
census: __________________ chart data: _________________________ lab data: __________________________ pharmacy data: _____________________ outpatient data: _____________________ other: _____________________________ | ||||||||||||||||
Extent of prior use: (e.g., number/type of organizations) |
None Single Site Single organization/ Multiple Sites Multiple organizations | ||||||||||||||||
Current Status |
measure defined
but not pilot tested pilot testing complete but not implemented implemented without pilot testing tested and implemented and still in use tested and implemented but discontinued | ||||||||||||||||
Scientific support for measure (e.g., expert panel, published guideline, clinical trials, other empiric research) Check all that apply |
published
guideline(s) clinician/expert panel(s) review of published literature (especially RCTs or equivalent) application or revision of pre-existing instruments or measures consensus within user group theory/concept only | ||||||||||||||||
Reference Citations: | List the publications according to the style from the software program EndNote. | ||||||||||||||||
Validity |
face
validity consensual validity criterion validity (gold standard measure) predictive validity construct validity (correlated with other measures in the absence of a gold standard) other none | ||||||||||||||||
Risk Adjustment: |
none stratified/subgroup analysis paired/matched data at patient level risk-adjustment using publicly or commercially available software risk-adjustment devised specifically for this measure and condition | ||||||||||||||||
Abstractor Comments: |
Risk-Adjustment Method Data Collection Instrument
UCSF-Stanford EPC/AHCPR
HCUP QI
Risk-Adjustment Method Header | |||||||||||||||||
Method Name: | |||||||||||||||||
Method Code: | System assigned | ||||||||||||||||
Year Developed: | |||||||||||||||||
Year Most Recently Update (" Update"= Change in risk adjustment strategy) (if applicable) | |||||||||||||||||
Developer
| |||||||||||||||||
Contact
| |||||||||||||||||
| |||||||||||||||||
Risk-Adjustment Method Detail | |||||||||||||||||
Adjustment Rationale: An explanation of why the adjustment is necessary to reduce or remove the influences of confounding patient factors | |||||||||||||||||
Classification or analytic approach (e.g., stratification (number of strata), logistic regression, linear regression, etc.) Check all that apply |
Stratification Logistic regression Linear regression Other | ||||||||||||||||
System development method (e.g., empirical model, score based on empirical model, clinical judgment, etc.) Check all that apply |
Logistic
regression Score based on empirical model A priori/ Clinical Judgement Other | ||||||||||||||||
Published performance: discrimination (e.g., the extent to which the model predicts higher probabilities of an event for those who experience the event) | |||||||||||||||||
Published performance: calibration (e.g., does the mean of the predicted equal the mean of the actual for the entire population and for population subgroups) | |||||||||||||||||
Co-morbidities: Pre-existing diseases or conditions | |||||||||||||||||
Severity of Illness Classification: (AJCC staging, ASA-PS classification for surgical patients) | |||||||||||||||||
Patient Demographics (e.g., age and gender) | |||||||||||||||||
Longitudinal Data Required: The measure requires the ability to match patient discharges over time |
Yes No | ||||||||||||||||
Additional Data Sources Required: (e.g.,chart review, registry data) Check all that apply, indicate specific data source (e.g. population/ census birth certificate) |
population/
census: __________________ chart data: ________________________ lab data: __________________________ pharmacy data: _____________________ outpatient data: _____________________ other: ____________________________ | ||||||||||||||||
Extent of prior or current use: (e.g., number/type of organizations) |
None Single Site Single organization/ Multiple Sites Multiple organizations | ||||||||||||||||
Reference Citations: | List the publications according to the style from the software program EndNote. | ||||||||||||||||
Abstractor Comments: |
Screener's Initials:
Date Screened:
Indicator Data Screening Instrument
UCSF-Stanford EPC/AHCPR HCUP
QI
Measure Header | |||||
Lead Author: | |||||
Article Title: | |||||
Year Published: | |||||
Measure Detail | |||||
Type of Measure: The activity or area of major concentration |
Mortality Readmission Complication length of stay avoidable hospitalization potentially overused procedure potentially underused procedure other | ||||
Type of Measure: (structure/process/proxy-outcome/outcome) | |||||
Enhancement Area: These are the areas AHCPR has asked us to focus on. You may choose more than one- as many as are applicable. | Chronic medical condition | Avoid. Hospit. | Pediatrics | New Technol. | None |
Clinical Domain: One of these options should be chosen based on article. | Medica l | surgical | pediatric | obstetric | psychiatric |
Measure Rationale | |||||
Longitudinal Data Required: The measure requires the ability to match patient discharges over time |
yes no | ||||
Additional Data Sources Required: (e.g., area population counts, etc.) |
population/
census chart data lab data pharmacy data outpatient data other |
- Data Collection Instruments - Refinement of the HCUP Quality IndicatorsData Collection Instruments - Refinement of the HCUP Quality Indicators
Your browsing activity is empty.
Activity recording is turned off.
See more...